Abstract
Objective
To examine the relationship of visual function as assessed by visual acuity, contrast sensitivity, and multifocal electroretinography (mfERG) to macular structural and microvascular measures on optical coherence tomography (OCT) and angiography (OCTA) in individuals with diabetes.
Methods
This is a prospective observational study conducted at a tertiary eye care centre in India. Right eyes of 121 adults with type 2 diabetes with no diabetic retinopathy (DR), mild or moderate nonproliferative DR (NPDR) were examined. Severe NPDR, proliferative DR and diabetic macular oedema were excluded. Participants underwent assessment of glycated haemoglobin (HbA1C), blood pressure, best corrected visual acuity (LogMAR), contrast sensitivity (CS), mfERG, ultrawide field fundus photography, OCT and OCTA. Correlations were assessed by Spearman’s rank correlation (rho).
Results
Of the total of 121 eyes, 89 had No DR, 32 had mild to moderate NPDR. In the No DR group, the LogMAR acuity was significantly and negatively correlated to central subfoveal thickness (CST) (rho = −0.420), macular vessel density (rho = −0.270) and perfusion (rho = −0.270). (ii) Contrast sensitivity correlated to foveal avascular zone circularity (rho = 0.297); (iii) mfERG P1 response densities were better with higher macular perfusion index (rho = 0.240). In the NPDR group, the LogMAR acuity also showed a significant negative correlation to CST (rho = −0.379). Other correlations were not significant.
Conclusion
Retinal and visual functional changes are evident in diabetic patients with No DR and are correlated to subclinical retinal structural changes detectable using multimodal imaging.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $6.61 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
Cusick M, SanGiovanni JP, Chew EY, Csaky KG, Hall-Shimel K, Reed GF, et al. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol. 2005;139:1042–1050.
Roh M, Selivanova A, Shin HJ, Miller JW, Jackson ML. Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. PLoS One. 2018;13:e0196481 https://doi.org/10.1371/journal.pone.0196481
Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, et al. Diabetic retinopathy, seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55:2401–11.
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102:783–91.
Han Y, Bearse MA, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:948–54.
Shapley R, Enroth-Cugell C. Visual adaptation and retinal gain controls. Prog Retinal Res. 1984;3:263–346.
Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The lens opacities classification system III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831–6.
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–82.
Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012;124:1–13.
Sen P, Roy R, Maru S Ravi. Evaluation of focal retinal function using multifocal electroretinography in patients with X-linked retinoschisis. Can J Ophthalmol. 2010;45:509–13.
Poh S, Tham YC, Chee ML, Dai W, Majithia S, Soh ZD, et al. Association between macular thickness profiles and visual function in healthy eyes: The Singapore Epidemiology of Eye Diseases (SEED) Study. Sci Rep. 2020;10:1–7.
Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M.Diabetic Retinopathy Clinical Research Network et al. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol.2012;130:1153–61.
Noma H, Funatsu H, Harino S, Nagaoka T, Mimura T, Hori S. Influence of macular microcirculation and retinal thickness on visual acuity in patients with branch retinal vein occlusion and macular edema. Jpn J Ophthalmol. 2010;54:430–4.
Samara WA, Shahlaee A, Sridhar J, Khan MA, Ho AC, Hsu J. Quantitative optical coherence tomography angiography features and visual function in eyes with branch retinal vein occlusion. Am J Ophthalmol. 2016;166:76–83.
Jeon SJ, Park HYL, Park CK. Effect of macular vascular density on central visual function and macular structure in glaucoma patients. Sci Rep. 2018;8:16009 https://doi.org/10.1038/s41598-018-34417-4
Hyvärinen L, Laurinen P, Rovamo J. Contrast sensitivity in evaluation of visual impairment due to macular degeneration and optic nerve lesions. Acta Ophthalmol. 1983;61:161–170.
Sokol S, Moskowitz A, Skarf B, Evans R, Molich M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103:51–54.
Marmor MF. Contrast sensitivity versus visual acuity in retinal disease. Br J Ophthalmol. 1986;70:553–9.
Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37:886–97.
Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic Physiol Opt. 1998;18:3–12.
Heravian J, Shoeibi N, Azimi A, Yasini S, Ostadimoghaddam H, Yekta AA, et al. Evaluation of contrast sensitivity, color vision and visual acuity in patients with and without diabetes. Iran J Ophthalmol. 2010;22:33–40.
Shoshani YZ, Harris A, Rusia D, Spaeth GL, Siesky B, Pollack A, et al. Contrast sensitivity, ocular blood flow and their potential role in assessing ischaemic retinal disease. Acta Ophthalmol. 2011;89:e382–395.
Gella L, Raman R, Pal SS, Ganesan S, Sharma T. Contrast sensitivity and its determinants in people with diabetes, SN-DREAMS-II, Report No 6. Eye. 2017;31:460–466.
Harris A, Arend O, Danis RP, Evans D, Wolf S, Reim M. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol. 1996;80:209–13.
Arend A, Remky D, Evans R, Stüber A. Harris. Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes. Invest Ophthalmol Vis Sci. 1997;38:1819–24.
Liu L, Gao J, Bao W, Hu C, Xu Y, Zhao B, et al. Analysis of foveal microvascular abnormalities in diabetic retinopathy using optical coherence tomography angiography with projection artifact removal. J Ophthalmol. 2018. https://doi.org/10.1155/2018/3926745
Pescosolido N, Barbato A, Stefanucci A, Buomprisco G. Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy. J Diabetes Res. 2015. https://doi.org/10.1155/2015/319692
Bearse MA Jr, Adams AJ, Han Y, Schneck ME, Ng J, Bronson-Castain K, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Retinal Eye Res. 2006;25:425–48.
Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638–51.
Frydkjaer-Olsen U, Soegaard Hansen R, Simó R, Cunha-Vaz J, Peto T, Grauslund J.EUROCONDOR Correlation between retinal vessel calibre and neurodegeneration in patients with type 2 diabetes mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Ophthalmic Res. 2016;56:10–16.
Sampson DM, Gong P, An D, Menghini M, Hansen A, Mackey DA, et al. Axial length variation impacts on superficial retinal vessel density and foveal avascular zone area measurements using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58:3065–72.
Funding
This work was supported by the DBT/Wellcome Trust India Alliance Fellowship [grant number IA/CPHE/16/1/502670] awarded to Dr Sangeetha Srinivasan.
Author information
Authors and Affiliations
Contributions
SS and RRN were responsible for designing the study; SS obtained funding, screened, examined patients, performed data analysis, interpreted results, wrote the paper; SS, SSD, MB interpreted the results, critically reviewed the manuscript. SS, SSD, RRN, RR, AM, RAM, VK, MB approved the content of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Srinivasan, S., Sobha Sivaprasad, Rajalakshmi, R. et al. Retinal structure–function correlation in type 2 diabetes. Eye 36, 1865–1871 (2022). https://doi.org/10.1038/s41433-021-01761-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-021-01761-1